Max Critchlow

Process Development Chemist, Drug Substance Synthesis PR&D

Home
Ask-the-experts
Max Critchlow - Process Development Chemist, Drug Substance Synthesis PR&D

About

Clinical Pharmacology

Clinical Pharmacology Info Sheet

10 March 2025 Read More

Latest news from Quotient Sciences

More News

News & Announcements, Articles & Publications, Thierry Van Nieuwenhove Thierry Van Nieuwenhove on the Future of CDMO Partnerships By: Thierry Van Nieuwenhove

News & Announcements, Translational Pharmaceutics®, Articles & Publications BioPharm International interviews Helen Baker about how Quotient Sciences is optimizing drug development

News & Announcements, Philadelphia, PA Quotient Sciences completes project to improve high potency handling at Philadelphia, Pa. facility

More News